EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Redox Regulation of PPAR γ in Polarized Macrophages

Verena Trümper, Ilka Wittig, Juliana Heidler, Florian Richter, Bernhard Brüne, Andreas von Knethen

PPAR Research · 2020-07-01 · 2020 · 1-16

DOI: 10.1155/2020/8253831 ↗
AbstractBibliografische Angaben

Abstract

The peroxisome proliferator-activated receptor (PPAR γ ) is a central mediator of cellular lipid metabolism and immune cell responses during inflammation. This is facilitated by its role as a transcription factor as well as a DNA-independent protein interaction partner. We addressed how the cellular redox milieu in the cytosol and the nucleus of lipopolysaccharide (LPS)/interferon- γ - (IFN γ -) and interleukin-4- (IL4-) polarized macrophages (M Φ ) initiates posttranslational modifications of PPAR γ , that in turn alter its protein function. Using the redox-sensitive GFP2 (roGFP2), we validated oxidizing and reducing conditions following classical and alternative activation of M Φ , while the redox status of PPAR γ was determined via mass spectrometry. Cysteine residues located in the zinc finger regions (amino acid fragments AA 90-115, AA 116-130, and AA 160-167) of PPAR γ were highly oxidized, accompanied by phosphorylation of serine 82 in response to LPS/IFN γ , whereas IL4-stimulation provoked minor serine 82 phosphorylation and less cysteine oxidation, favoring a reductive milieu. Mutating these cysteines to alanine to mimic a redox modification decreased PPAR γ -dependent reporter gene transactivation supporting a functional shift of PPAR γ associated with the M Φ phenotype. These data suggest distinct mechanisms for regulating PPAR γ function based on the redox state of M Φ .

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →